Old Web
English
Sign In
Acemap
>
Paper
>
FP12.06 GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab
FP12.06 GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab
2021
Edoardo Lenci
Luca Cantini
Silvia Rinaldi
Federica Pecci
Valeria Cognigni
Veronica Agostinelli
Giulia Mentrasti
Nicoletta Ranallo
Alessio Lupi
Francesco Paoloni
Alessio Cortellini
Corrado Ficorella
Rita Chiari
M. Di Maio
Joachim G.J.V. Aerts
Anne-Marie C. Dingemans
Linda Nicolardi
Andrea Caglio
Sophie Aerts
R. Berardi
Keywords:
Internal medicine
Medicine
first line
Oncology
Pembrolizumab
Outcome (game theory)
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]